| 摘要 |
FIELD: medicine, pharmaceutics. ^ SUBSTANCE: invention relates to medicine, namely to pharmacology and cardiology, and deals with prevention of lipid exchange disorders. For this purpose, at the background of introduction of lovastatin in average therapeutic dose, additionally, intramuscularly introduced is 3-oxy-6-methyl-2-ethyl-pyridine succinate, also in dose 0.7 mg/kg daily 1 time per day during 10 days. ^ EFFECT: method ensures prolongation of hypolipidemic effect of lovastatin after its cancelling. ^ 2 tbl, 4 dwg, 2 ex |
